Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Principia Biopharma Inc (PRNB)

Principia Biopharma Inc (PRNB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,322,560
  • Shares Outstanding, K 33,209
  • Annual Sales, $ 35,160 K
  • Annual Income, $ -53,790 K
  • 60-Month Beta 0.86
  • Price/Sales 94.40
  • Price/Cash Flow N/A
  • Price/Book 9.41
Trade PRNB with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.41
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/03/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.85
  • Number of Estimates 4
  • High Estimate 0.30
  • Low Estimate -1.42
  • Prior Year -0.93
  • Growth Rate Est. (year over year) +8.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
99.76 +0.29%
on 09/04/20
101.25 -1.19%
on 08/26/20
-1.02 (-1.01%)
since 08/25/20
3-Month
53.36 +87.50%
on 07/09/20
101.89 -1.81%
on 08/25/20
+40.58 (+68.24%)
since 06/25/20
52-Week
25.35 +294.67%
on 10/02/19
101.89 -1.81%
on 08/25/20
+69.41 (+226.53%)
since 09/25/19

Most Recent Stories

More News
Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib

Trial enrolled patients ahead of originally anticipated timeline despite COVID-19 pandemic

PRNB : 100.05 (+0.10%)
Neoleukin Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Update

- NL-201 IND submission anticipated by year end 2020 -

NLTX : 0.6675 (+4.30%)
PRNB : 100.05 (+0.10%)
Principia Announces First Patient Dosed in Phase 2A Trial of Rilzabrutinib in IgG4-Related Disease

SOUTH SAN FRANCISCO, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune mediated diseases,...

PRNB : 100.05 (+0.10%)
Neoleukin Therapeutics Announces Appointment of Martin Babler to Board of Directors

SEATTLE, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design  de novo...

NLTX : 0.6675 (+4.30%)
PRNB : 100.05 (+0.10%)
Moore Kuehn Encourages SBPH, PFNX, VAR, and PRNB Investors to Contact Law Firm

NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether...

SBPH : 4.8400 (unch)
VAR : 177.07 (-0.02%)
PRNB : 100.05 (+0.10%)
PFNX : 12.75 (-0.08%)
INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – PRNB, VAR, PTI, LVGO

NEW YORK, NY / ACCESSWIRE / September 5, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: Principia Biopharma Inc. (NASDAQ:PRNB) concerning potential violations...

PRNB : 100.05 (+0.10%)
VAR : 177.07 (-0.02%)
PTI : 1.1100 (-3.48%)
LVGO : 139.77 (-3.87%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of PRNB, CBMG, PFNX, and VAR Buyouts

WILMINGTON, Del., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

PRNB : 100.05 (+0.10%)
CBMG : 19.75 (unch)
VAR : 177.07 (-0.02%)
INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – PRNB, BLDR, PFNX, MVC

NEW YORK, NY / ACCESSWIRE / September 1, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate: Principia Biopharma Inc. (NASDAQ:PRNB) concerning potential violations of...

PRNB : 100.05 (+0.10%)
BLDR : 60.28 (+2.31%)
PFNX : 12.75 (-0.08%)
MVC : 9.12 (+2.59%)
Lifshitz Law Firm, P.C. Announces Investigation of Cancer Genetics, Inc., Momenta Pharmaceuticals, Inc., Principia Biopharma Inc., and Yintech Investment Holdings Limited

NEW YORK, Sept. 01, 2020 (GLOBE NEWSWIRE) --

CGIX : 4.61 (-2.33%)
MNTA : 52.48 (-0.02%)
PRNB : 100.05 (+0.10%)
YIN : 7.25 (+0.14%)
SHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – PRNB, MNTA, PTI, BLDR

NEW YORK, NY / ACCESSWIRE / August 29, 2020 /Halper Sadeh LLP, a global investor rights law firm, continues to investigate: Principia Biopharma Inc. (NASDAQ:PRNB) concerning potential violations of the...

PRNB : 100.05 (+0.10%)
MNTA : 52.48 (-0.02%)
PTI : 1.1100 (-3.48%)
BLDR : 60.28 (+2.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Principia Biopharma Inc. is a clinical stage biopharmaceutical company. It offers reversible covalent small molecule drugs for the treatment of cancers. The company's product pipeline consists of PRN1008, PRN1371 and PRN2246 which are in clinical stage. Principia Biopharma Inc. is based in San Francisco,...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 100.54
1st Resistance Point 100.30
Last Price 100.05
1st Support Level 99.88
2nd Support Level 99.70
3rd Support Level N/A

See More

52-Week High 101.89
Last Price 100.05
Fibonacci 61.8% 72.65
Fibonacci 50% 63.62
Fibonacci 38.2% 54.59
52-Week Low 25.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar